The effect of rotenone on cell viability was determined by MTT cell viability assay in a dose-dependent manner (0.1, 0.5, 1, 5, and 10 μM) for 24 h in each neuroblastoma cell with/without GH (Figure 1B). This evidence concerns the gene GH1 and neuroblastoma.